These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4411662)

  • 1. A method for shifting from oral to intramuscular diphenylhydantoin administration.
    Wilder BJ; Serrano EE; Ramsey E; Buchanan RA
    Clin Pharmacol Ther; 1974 Sep; 16(3):507-13. PubMed ID: 4411662
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma diphenylhydantoin values after oral and intramuscular administration of diphenylhydantoin.
    Serrano EE; Roye DB; Hammer RH; Wilder BJ
    Neurology; 1973 Mar; 23(3):311-7. PubMed ID: 4735181
    [No Abstract]   [Full Text] [Related]  

  • 3. Diphenylhydantoin in children. Pharmacology and efficacy.
    Borofsky LG; Louis S; Kutt H
    Neurology; 1973 Sep; 23(9):967-72. PubMed ID: 4737688
    [No Abstract]   [Full Text] [Related]  

  • 4. Diphenylhydantoin and epilepsy management.
    Easton JD
    Ann Intern Med; 1972 Sep; 77(3):421-3. PubMed ID: 5053732
    [No Abstract]   [Full Text] [Related]  

  • 5. Inadequate serum levels after intramuscular administration of diphenylhydantoin.
    Wilensky AJ; Lowden JA
    Neurology; 1973 Mar; 23(3):318-24. PubMed ID: 4735182
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of dosage increments on blood phenytoin concentrations.
    Bochner F; Hooper WD; Tyrer JH; Eadie MJ
    J Neurol Neurosurg Psychiatry; 1972 Dec; 35(6):873-6. PubMed ID: 4647859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [5,5-Diphenylhydantoin (hydantoinal Polfa)].
    Pakszys W
    Neurol Neurochir Pol; 1973; 7(1):79-84. PubMed ID: 4570505
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Bioavailability of drugs after intramuscular injection.
    Cameron JD; Hedley DW
    Lancet; 1975 Mar; 1(7908):700. PubMed ID: 47135
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacodynamic aspects of phenobarbital (PB) and diphenylhydantoin (DPH). Correlations with clinical findings].
    Denegri M; Luciano L
    Rev Neuropsychiatr Infant; 1972; 20(3):375-83. PubMed ID: 5055027
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral and intramuscular phenytoin.
    Wilder BJ; Ramsay RE
    Clin Pharmacol Ther; 1976 Mar; 19(3):360-4. PubMed ID: 770051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One daily dose of diphenylhydantoin for patients with epilepsy.
    Strandjord RE; Johannessen SI; Halpern LM
    Epilepsia; 1974 Sep; 15(3):317-27. PubMed ID: 4527914
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of serum diphenylhydantoin during antiepileptic therapy].
    Müller-Stüler M
    Nervenarzt; 1976 Apr; 47(4):244-7. PubMed ID: 1272481
    [No Abstract]   [Full Text] [Related]  

  • 13. One daily dose of diphenylhydantoin (DPH) to patients with epilepsy.
    Strandjord RE; Johannessen SI
    Acta Neurol Scand Suppl; 1972; 51():499-500. PubMed ID: 4514392
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of blood levels with oral and intramuscular diphenylhydantoin.
    Cantu RC; Schwab RS; Timberlake WH
    Neurology; 1968 Aug; 18(8):782-4. PubMed ID: 5692338
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute intoxication with 5,5-diphenylhydantoin (Dilantin) associated with impairment of biotransformation. Plasma levels and urinary metabolites; and studies in healthy volunteers.
    Gerber N; Lynn R; Oates J
    Ann Intern Med; 1972 Nov; 77(5):765-71. PubMed ID: 4628215
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspects of diphenylhydantoin metabolism.
    Eadie MJ; Tyrer JH; Hooper WD
    Proc Aust Assoc Neurol; 1970; 7():7-13. PubMed ID: 5514827
    [No Abstract]   [Full Text] [Related]  

  • 17. Diphenylhydantoin.
    Glazko AJ
    Pharmacology; 1972; 8(1):163-77. PubMed ID: 4630160
    [No Abstract]   [Full Text] [Related]  

  • 18. Diphenylhydantoin metabolism in uremia.
    Letteri JM; Mellk H; Louis S; Kutt H; Durante P; Glazko A
    N Engl J Med; 1971 Sep; 285(12):648-52. PubMed ID: 5563477
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies of the effect of 5,5-diphenylhydantoin on the bioelectric activity of the brain in epilepsy].
    Domzal T; Gajkowski K
    Neurol Neurochir Pol; 1971; 5(3):301-6. PubMed ID: 5000628
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic disposition of diphenylhydantoin in normal human subjects following intravenous administration.
    Glazko AJ; Chang T; Baukema J; Dill WA; Goulet JR; Buchanan RA
    Clin Pharmacol Ther; 1969; 10(4):498-504. PubMed ID: 5793754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.